These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 24443368

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Response to growth hormone treatment in Prader-Willi syndrome: auxological criteria versus genetic diagnosis.
    Scheermeyer E, Hughes I, Harris M, Ambler G, Crock P, Verge CF, Craig ME, Bergman P, Werther G, van Driel M, Davies PS, Choong CS.
    J Paediatr Child Health; 2013 Dec; 49(12):1045-51. PubMed ID: 23781979
    [Abstract] [Full Text] [Related]

  • 6. Impairment of adipose tissue in Prader-Willi syndrome rescued by growth hormone treatment.
    Cadoudal T, Buléon M, Sengenès C, Diene G, Desneulin F, Molinas C, Eddiry S, Conte-Auriol F, Daviaud D, Martin PG, Bouloumié A, Salles JP, Tauber M, Valet P.
    Int J Obes (Lond); 2014 Sep; 38(9):1234-40. PubMed ID: 24406482
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome.
    Angulo M, Castro-Magana M, Mazur B, Canas JA, Vitollo PM, Sarrantonio M.
    J Pediatr Endocrinol Metab; 1996 Sep; 9(3):393-400. PubMed ID: 8887149
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
    Feigerlová E, Diene G, Oliver I, Gennero I, Salles JP, Arnaud C, Tauber M.
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
    [Abstract] [Full Text] [Related]

  • 11. Safety and effectiveness of growth hormone therapy in infants with Prader-Willi syndrome younger than 2 years: a prospective study.
    Corripio R, Tubau C, Calvo L, Brun C, Capdevila N, Larramona H, Gabau E.
    J Pediatr Endocrinol Metab; 2019 Aug 27; 32(8):879-884. PubMed ID: 31271556
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.
    de Lind van Wijngaarden RF, Siemensma EP, Festen DA, Otten BJ, van Mil EG, Rotteveel J, Odink RJ, Bindels-de Heus GC, van Leeuwen M, Haring DA, Bocca G, Houdijk EC, Hoorweg-Nijman JJ, Vreuls RC, Jira PE, van Trotsenburg AS, Bakker B, Schroor EJ, Pilon JW, Wit JM, Drop SL, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2009 Nov 27; 94(11):4205-15. PubMed ID: 19837938
    [Abstract] [Full Text] [Related]

  • 13. Effects of growth hormone treatment on height, weight, and obesity in Taiwanese patients with Prader-Willi syndrome.
    Lin HY, Lin SP, Tsai LP, Chao MC, Chen MR, Chuang CK, Huang CY, Tsai FJ, Chou IC, Chiu PC, Huang CH, Yen JL, Lin JL, Kuo PL.
    J Chin Med Assoc; 2008 Jun 27; 71(6):305-9. PubMed ID: 18567561
    [Abstract] [Full Text] [Related]

  • 14. Clinical Characteristics and Growth Hormone Treatment in Patients with Prader-Willi Syndrome.
    Dağdeviren Çakır A, Baş F, Akın O, Şıklar Z, Özcabı B, Berberoğlu M, Kardelen AD, Bayramoğlu E, Poyrazoğlu Ş, Aydın M, Törel Ergür A, Gökşen D, Bolu S, Aycan Z, Tüysüz B, Ercan O, Evliyaoğlu O.
    J Clin Res Pediatr Endocrinol; 2021 Aug 23; 13(3):308-319. PubMed ID: 33565750
    [Abstract] [Full Text] [Related]

  • 15. What is the value of growth hormone therapy in Prader Willi syndrome?
    Bridges N.
    Arch Dis Child; 2014 Feb 23; 99(2):166-70. PubMed ID: 24162007
    [Abstract] [Full Text] [Related]

  • 16. Sustained benefits of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome are dose-dependent.
    Carrel AL, Myers SE, Whitman BY, Allen DB.
    J Pediatr Endocrinol Metab; 2001 Feb 23; 14(8):1097-105. PubMed ID: 11592566
    [Abstract] [Full Text] [Related]

  • 17. Bone mineral density in young adults with Prader-Willi syndrome: A randomized, placebo-controlled, crossover GH trial.
    Donze SH, Kuppens RJ, Bakker NE, van Alfen-van der Velden JAEM, Hokken-Koelega ACS.
    Clin Endocrinol (Oxf); 2018 Jun 23; 88(6):806-812. PubMed ID: 29418016
    [Abstract] [Full Text] [Related]

  • 18. Peptides associated with hyperphagia in adults with Prader-Willi syndrome before and during GH treatment.
    Höybye C, Barkeling B, Espelund U, Petersson M, Thorén M.
    Growth Horm IGF Res; 2003 Dec 23; 13(6):322-7. PubMed ID: 14624765
    [Abstract] [Full Text] [Related]

  • 19. Outcomes of growth hormone treatment in children with Prader-Willi syndrome over a 30-year period: a single tertiary center experience.
    Gamage DS, Ambler G, Chan A, Srinivasan S, Maguire AM, Cho YH.
    J Pediatr Endocrinol Metab; 2024 Aug 27; 37(8):680-685. PubMed ID: 39089289
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.